Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Mind-Body Benefits of Eye Movement Desensitization and Reprocessing (Emdr) in Acute Respiratory Infections: A Randomized Clinical Study of Psychophysiological Outcomes
fatemeh Rahiminejad
fatemeh Rahiminejad

Assistant Professor of Psychiatry

Department Psychiatry

School of Medicine

Roozbeh Hospital

Tehran University of Medical Sciences

All Documents
1. Challenges and Solutions of Building Trust in Mental Health Services: Hearing the Voices of Iranian Medical Students Through Community Participation, BMC Psychiatry (2026)
2. Rosiglitazone Adjunct to Sertraline for Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial, Depression and Anxiety (2026)
3. Depression Is Associated With the Nonmotor Symptoms of Parkinson's Disease: A Comparative Analysis, Health Science Reports (2024)
4. Prevalence of Psychosis and Its Relationship With Substance Use Disorder in Patients With Bipolar Disorder in Iran, Journal of Affective Disorders Reports (2024)
5. Assessing the Level of Concentration and Full Presence of Perfectionist Students in Online Education During the Covid-19 Pandemic, Journal of Iranian Medical Council (2023)
6. Comorbidity of Adult Adhd and Substance Use Disorder in a Sample of Inpatients Bipolar Disorder in Iran, BMC Psychiatry (2022)
7. Measurement of Post-Treatment Changes in Brain Metabolites in Patients With Generalized Anxiety Disorder Using Magnetic Resonance Spectroscopy, Journal of Biomedical Physics and Engineering (2022)
8. Prevalence of Bipolar Disorder Among Patients With Suicidal Ideation, Recent Aggression and Self-Harm, Referred to the Psychiatric Hospital Emergency Department in Iran, Asian Journal of Psychiatry (2021)
9. Pregnenolone As an Adjunct to Risperidone for Treatment of Women With Schizophrenia: A Randomized Double-Blind Placebo-Controlled Clinical Trial, Journal of Psychiatric Research (2017)
10. Minocycline Combination Therapy With Fluvoxamine in Moderate-To-Severe Obsessive–Compulsive Disorder: A Placebo-Controlled, Double-Blind, Randomized Trial, Psychiatry and Clinical Neurosciences (2016)